816 related articles for article (PubMed ID: 22410655)
1. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian Patients.
Chakraborty B; Vishnoi G; Goswami B; Gowda SH; Chowdhury D; Agarwal S
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e159-67. PubMed ID: 23253530
[TBL] [Abstract][Full Text] [Related]
3. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
Maguire J; Thakkinstian A; Levi C; Lincz L; Bisset L; Sturm J; Scott R; Whyte S; Attia J
J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke.
Pola R; Flex A; Gaetani E; Flore R; Serricchio M; Pola P
Stroke; 2003 Apr; 34(4):881-5. PubMed ID: 12637697
[TBL] [Abstract][Full Text] [Related]
5. Anemia is associated with poor outcomes in patients with less severe ischemic stroke.
Sico JJ; Concato J; Wells CK; Lo AC; Nadeau SE; Williams LS; Peixoto AJ; Gorman M; Boice JL; Bravata DM
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):271-8. PubMed ID: 22100828
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.
Ji R; Jia J; Ma X; Wu J; Zhang Y; Xu L
Cerebrovasc Dis; 2011; 32(3):261-8. PubMed ID: 21893978
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile.
Vallejos J; Jaramillo A; Reyes A; Illanes S; Orellana P; Manterola J; Díaz V
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):621-8. PubMed ID: 21602057
[TBL] [Abstract][Full Text] [Related]
8. Major Adipokines and the -420C>G Resistin Gene Polymorphism as Predictors of Acute Ischemic Stroke Severity and In-Hospital Outcome.
Bouziana SD; Tziomalos K; Goulas A; Vyzantiadis TA; Panderi A; Ηatzitolios AΙ
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):963-970. PubMed ID: 29217361
[TBL] [Abstract][Full Text] [Related]
9. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events.
Greisenegger S; Endler G; Haering D; Schillinger M; Lang W; Lalouschek W; Mannhalter C
Thromb Res; 2003 Jun; 110(4):181-6. PubMed ID: 14512079
[TBL] [Abstract][Full Text] [Related]
10. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes.
Chamorro A; Revilla M; Obach V; Vargas M; Planas AM
Cerebrovasc Dis; 2005; 19(2):91-5. PubMed ID: 15608432
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10-1082 promoter polymorphism and ischemic stroke risk in a South Indian population.
Munshi A; Rajeshwar K; Kaul S; Al-Hazzani A; Alshatwi AA; Sai Babu M; Usha A; Jyothy A
Cytokine; 2010 Dec; 52(3):221-4. PubMed ID: 21030268
[TBL] [Abstract][Full Text] [Related]
13. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
14. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
Koton S; Molshatzki N; Bornstein NM; Tanne D
Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
[TBL] [Abstract][Full Text] [Related]
15. APOE does not predict poor outcome 1 year after ischemic stroke.
Sarzyńska-Długosz I; Gromadzka G; Barańska-Gieruszczak M; Ciesielska A; Członkowska A
Neurol Res; 2007 Jan; 29(1):64-9. PubMed ID: 17427278
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.
Chakraborty B; Vishnoi G; Gowda SH; Goswami B
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e402-e407. PubMed ID: 25359504
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
[TBL] [Abstract][Full Text] [Related]
18. Association between interleukin-6 (G174C and C572G) promoter gene polymorphisms and risk of ischemic stroke in North Indian population: a case-control study.
Kumar P; Kumar A; Sagar R; Misra S; Faruq M; Suroliya V; Vivekanandhan S; Kumar Srivastava A; Prasad K
Neurol Res; 2016 Jan; 38(1):69-74. PubMed ID: 26883819
[TBL] [Abstract][Full Text] [Related]
19. Association of ALOX5AP1 SG13S114T/A variant with ischemic stroke, stroke subtypes and aspirin resistance.
Sharma V; Dadheech S; Kaul S; Jyothy A; Munshi A
J Neurol Sci; 2013 Aug; 331(1-2):108-13. PubMed ID: 23746795
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
